MCK(McKesson Corporation) 的财务报表:医疗保健,医药分销。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2022-03-31 | FY 截至 2023-03-31 | FY 截至 2024-03-31 | FY 截至 2025-03-31 | FY 截至 2026-03-31 |
|---|---|---|---|---|---|
| 营业收入 | $263.97B | $276.71B | $308.95B | $359.05B | $403.43B |
| 毛利润 | $13.13B | $12.36B | $12.83B | $13.32B | $14.55B |
| 营业利润 | $2.04B | $4.38B | $3.91B | $4.42B | $6.21B |
| 净利润 | $1.11B | $3.56B | $3.00B | $3.29B | $4.76B |
| 经营现金流 | $4.43B | $5.16B | $4.31B | $6.08B | $6.16B |
| 自由现金流 | $4.05B | $4.77B | $3.88B | $5.55B | $5.72B |
| 摊薄每股收益 | $7.23 | $25.03 | $22.39 | $25.72 | $38.38 |